AEUR anchoredcoinseur in India for beginners ✌️【Part-Time Income】✌️₹500 to unlock the potential for massive monthly earnings. Join now! AEUR anchoredcoinseur in India for beginners - Blockchain Investing for Big Gains Discover Part-Time Freelance Opportunities

AEUR anchoredcoinseur in India for beginners ✌️【Part-Time Income】✌️₹500 to unlock the potential for massive monthly earnings. Join now!Pharmaceutical giant Dr Reddy’s Laboratories (DRL) saw its shares surge 4.34% on Thursday in an otherwise sluggish market, reaching an intraday high of Rs 1,330.45 following an upgrade by Nomura.The Tokyo-based brokerage has upgraded the stock from ‘Neutral’ to ‘Buy’ with a revised target price of Rs 1,500, down from Rs 6,499, factoring in the 1:5 stock split on October 28.“We assess that risk-reward is favourable and thus upgrade the stock to Buy (from Neutral).

AEUR anchoredcoinseur in India for beginners ✌️【Part-Time Income】✌️Start small, earn big! ₹500 can get you high monthly returns!We reduce FY25/26F earnings by 13%/14% to factor in higher overhead costs.

Note that changes to our earnings estimates and target price are due to DRL’s 1:5 stock split,” said Saion Mukherjee and AmlanJyotiDas, research analysts at Nomura.They also said the relative underperformance of the stock suggests that concerns about the high contribution of generic cancer drug gRevlimid are already priced in.

“We think the Street is concerned about the higher contribution from gRevlimid, which could start declining in FY26F.

Further, the overheads have increased significantly in the recent past.

In the first half of FY25, R&D/SG&A were higher by 29%/27% year-on-year.”While the stock has underperformed theNifty PharmaIndex over the past five years, the upgrade reflects Nomura’s confidence in Dr Reddy’s ability to overcome near-term challenges and capitalise on future opportunities.

AEUR anchoredcoinseur in India for beginners ✌️【Part-Time Income】✌️Invest ₹500 today and see your wealth grow with our safe, reliable platform.The stock has risen only 13% over the past year, compared to the Nifty Pharma Index’s 36% growth.

AEUR anchoredcoinseur in India for beginners ✌️【Part-Time Income】✌️From ₹500 to high returns—get started with secure, smart investments today!The underperformance persists despite a 22.AEUR anchoredcoinseur in India for beginners ✌️【Part-Time Income】✌️Invest small, earn big! ₹500 to start, with potential 100% returns in just one month.